Paul Tudor Jones Becton Dickinson & CO Call Options Transaction History

Tudor Investment Corp Et Al

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $1.17 Million - $1.28 Million	5,300 New	5,300 $1.28 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $560,280 - $594,552	-2,400 Reduced 48.98%	2,500 $618,000
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $371,584 - $427,568	1,600 Added 48.48%	4,900 $1.19 Million
Q3 2023 Nov 15, 2023	BUY	$254.9 - $283.59 $841,170 - $935,846	3,300 New	3,300 $853,000
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $742,186 - $873,494	-3,400 Reduced 79.07%	900 $228,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $219,429 - $1.14 Million	4,300 New	4,300 $956,000
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $492,954 - $578,382	-2,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $511,644 - $568,008	2,100 New	2,100 $559,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.